The role of cytokines in the regulation of NK cells in the tumor environment
- PMID: 30784898
- DOI: 10.1016/j.cyto.2019.02.001
The role of cytokines in the regulation of NK cells in the tumor environment
Abstract
Natural killer (NK) cells are innate lymphoid cells that are important effectors in the first line of defense toward transformed cells. This is mediated both by direct cytotoxic mechanisms and by production of immunoregulatory cytokines. Recent evidence has shown that NK cells also display memory, similar to the cells of the adaptive immune system. Cytokines are pivotal for the maturation, activation and survival of NK cells. Interleukins (IL)-2, IL-12, IL-15, IL-18, IL-21 and type I interferons positively regulate NK cell function, either independently or in cooperation, whereas other cytokines, such as IL-23 and IL-27, may enhance or suppress NK cell function depending on the context. In the tumor microenvironment, TGFβ, IL-10 and IL-6 suppress NK cell activity not only directly, but also indirectly, by affecting immunosuppressive cells and by antagonizing the effect of stimulatory cytokines, thereby dampening the antitumor response of NK cells and promoting subsequent tumor evasion and progression. Increased understanding of the NK cell response to cytokines has provided a better understanding of their impaired function in tumors which may aid in the development of novel immunotherapeutic strategies to enhance NK cell responses in cancer patients.
Keywords: Cytokines; Cytotoxicity; Immunotherapy; NK cells; Tumors.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Similar articles
-
Cytokine regulation of natural killer cell effector functions.Biofactors. 2010 Jul-Aug;36(4):274-88. doi: 10.1002/biof.107. Biofactors. 2010. PMID: 20623510 Review.
-
Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for Neuroblastoma.Clin Cancer Res. 2019 Jul 15;25(14):4400-4412. doi: 10.1158/1078-0432.CCR-18-3183. Epub 2019 Apr 22. Clin Cancer Res. 2019. PMID: 31010834 Free PMC article.
-
Tricking the balance: NK cells in anti-cancer immunity.Immunobiology. 2017 Jan;222(1):11-20. doi: 10.1016/j.imbio.2015.07.012. Epub 2015 Jul 26. Immunobiology. 2017. PMID: 26264743 Review.
-
The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines.Clin Cancer Res. 2007 Nov 1;13(21):6419-28. doi: 10.1158/1078-0432.CCR-07-0865. Epub 2007 Oct 25. Clin Cancer Res. 2007. PMID: 17962339
-
Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment.Front Immunol. 2021 Jun 17;12:683381. doi: 10.3389/fimmu.2021.683381. eCollection 2021. Front Immunol. 2021. PMID: 34220833 Free PMC article. Review.
Cited by
-
Allogeneic natural killer cell therapy.Blood. 2023 Feb 23;141(8):856-868. doi: 10.1182/blood.2022016200. Blood. 2023. PMID: 36416736 Free PMC article. Review.
-
Interleukin 15: A new intermediary in the effects of exercise and training on skeletal muscle and bone function.J Cell Mol Med. 2024 Nov;28(22):e70136. doi: 10.1111/jcmm.70136. J Cell Mol Med. 2024. PMID: 39601091 Free PMC article. Review.
-
Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment.Front Oncol. 2022 Nov 15;12:988956. doi: 10.3389/fonc.2022.988956. eCollection 2022. Front Oncol. 2022. PMID: 36457492 Free PMC article. Review.
-
Natural killer cells in clinical development as non-engineered, engineered, and combination therapies.J Hematol Oncol. 2022 Nov 8;15(1):164. doi: 10.1186/s13045-022-01382-5. J Hematol Oncol. 2022. PMID: 36348457 Free PMC article. Review.
-
Monalizumab: inhibiting the novel immune checkpoint NKG2A.J Immunother Cancer. 2019 Oct 17;7(1):263. doi: 10.1186/s40425-019-0761-3. J Immunother Cancer. 2019. PMID: 31623687 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous